Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Galena Biopharma GALE

"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

NDAQ:GALE - Post Discussion

Galena Biopharma > SHAREHOLDER ALERT !!!
View:
Post by Highrider7 on Feb 20, 2014 10:12am

SHAREHOLDER ALERT !!!

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of GALENA BIOPHARMA, INC. for Possible Breaches of Fiduciary Duty
18 Feb 2014 - ACQUIREMEDIA

NEW YORK--(BUSINESS WIRE)--Feb. 18, 2014-- Levi & Korsinsky is investigating Galena Biopharma, Inc. ("Galena Biopharma" or the "Company") (Nasdaq:GALE) for possible breaches of fiduciary duty. The investigation concerns whether a series of statements Galena Biopharma made regarding its business, prospects, and operations were materially false and misleading.

Click here to learn more about the investigation: https://zlk.9nl.com/galena-biopharma or call: 877-363-5972. There is no cost or obligation to you.

On February 14, 2014, Galena acknowledged that it had paid the investor relations firm The DreamTeam Group to promote the Company. The investigation concerns whether these promotional materials were misleading and/or omitted material information, and whether Company insiders took advantage of the positive press to sell significant amounts of shares for substantial profit.

If you own Gale Biopharma stock and wish to obtain additional information about the investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit https://zlk.9nl.com/galena-biopharma.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

 

Source: Levi & Korsinsky, LLP

Levi & Korsinsky, LLP
Joseph Levi, Esq. / Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 866-367-6510
www.zlk.com

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities